185 related articles for article (PubMed ID: 28847527)
21. Effect of intravenous ascorbic acid medication on serum levels of soluble transferrin receptor in hemodialysis patients.
Tarng DC; Hung SC; Huang TP
J Am Soc Nephrol; 2004 Sep; 15(9):2486-93. PubMed ID: 15339999
[TBL] [Abstract][Full Text] [Related]
22. Strong synergy of heat and modulated electromagnetic field in tumor cell killing.
Andocs G; Renner H; Balogh L; Fonyad L; Jakab C; Szasz A
Strahlenther Onkol; 2009 Feb; 185(2):120-6. PubMed ID: 19240999
[TBL] [Abstract][Full Text] [Related]
23. Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.
Garon EB; Ciuleanu TE; Arrieta O; Prabhash K; Syrigos KN; Goksel T; Park K; Gorbunova V; Kowalyszyn RD; Pikiel J; Czyzewicz G; Orlov SV; Lewanski CR; Thomas M; Bidoli P; Dakhil S; Gans S; Kim JH; Grigorescu A; Karaseva N; Reck M; Cappuzzo F; Alexandris E; Sashegyi A; Yurasov S; Pérol M
Lancet; 2014 Aug; 384(9944):665-73. PubMed ID: 24933332
[TBL] [Abstract][Full Text] [Related]
24. Clinical pharmacokinetics, safety, and preliminary efficacy evaluation of icotinib in patients with advanced non-small cell lung cancer.
Liu D; Zhang L; Wu Y; Jiang J; Tan F; Wang Y; Liu Y; Hu P
Lung Cancer; 2015 Sep; 89(3):262-7. PubMed ID: 26162563
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].
Huang F; Wang XL; Geng Y; Li MX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):507-9. PubMed ID: 15989803
[TBL] [Abstract][Full Text] [Related]
26. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F
J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761
[TBL] [Abstract][Full Text] [Related]
27. A brief report on the safety study of induction chemotherapy followed by synchronous radiotherapy and cetuximab in stage III non-small cell lung cancer (NSCLC): SCRATCH study.
Hughes S; Liong J; Miah A; Ahmad S; Leslie M; Harper P; Prendiville J; Shamash J; Subramaniam R; Gaya A; Spicer J; Landau D
J Thorac Oncol; 2008 Jun; 3(6):648-51. PubMed ID: 18520806
[TBL] [Abstract][Full Text] [Related]
28. Oxalic acid excretion after intravenous ascorbic acid administration.
Robitaille L; Mamer OA; Miller WH; Levine M; Assouline S; Melnychuk D; Rousseau C; Hoffer LJ
Metabolism; 2009 Feb; 58(2):263-9. PubMed ID: 19154961
[TBL] [Abstract][Full Text] [Related]
29. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.
Pradier O; Lederer K; Hille A; Weiss E; Christiansen H; Schmidberger H; Hess CF
J Cancer Res Clin Oncol; 2005 Apr; 131(4):261-9. PubMed ID: 15616830
[TBL] [Abstract][Full Text] [Related]
30. Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancer.
Miller VA; Rigas JR; Tong WP; Reid JR; Pisters KM; Grant SC; Heelan RT; Kris MG
Cancer Chemother Pharmacol; 1997; 40(5):415-8. PubMed ID: 9272118
[TBL] [Abstract][Full Text] [Related]
31. Phase I/II and pharmacokinetic study of intravenous vinflunine in combination with cisplatin for the treatment of chemonaive patients with advanced non-small-cell lung cancer.
Souquet PJ; Krzakowski M; Ramlau R; Sun XS; Lopez-Vivanco G; Puozzo C; Pouget JC; Pinel MC; Rosell R
Clin Lung Cancer; 2010 Mar; 11(2):105-13. PubMed ID: 20199976
[TBL] [Abstract][Full Text] [Related]
32. A phase I study and pharmacokinetics of irinotecan (CPT-11) and paclitaxel in patients with advanced non-small cell lung cancer.
Hotta K; Ueoka H; Kiura K; Tabata M; Kuyama S; Satoh K; Kozuki T; Hisamoto A; Hosokawa S; Fujiwara K; Tanimoto M
Lung Cancer; 2004 Jul; 45(1):77-84. PubMed ID: 15196737
[TBL] [Abstract][Full Text] [Related]
33. Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer.
Thienelt CD; Bunn PA; Hanna N; Rosenberg A; Needle MN; Long ME; Gustafson DL; Kelly K
J Clin Oncol; 2005 Dec; 23(34):8786-93. PubMed ID: 16246975
[TBL] [Abstract][Full Text] [Related]
34. Phase I study of the HER3-targeted antibody patritumab (U3-1287) combined with erlotinib in Japanese patients with non-small cell lung cancer.
Nishio M; Horiike A; Murakami H; Yamamoto N; Kaneda H; Nakagawa K; Horinouchi H; Nagashima M; Sekiguchi M; Tamura T
Lung Cancer; 2015 Jun; 88(3):275-81. PubMed ID: 25891541
[TBL] [Abstract][Full Text] [Related]
35. Fasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patients.
Luo J; Chen YJ; Chang LJ
Lung Cancer; 2012 May; 76(2):242-7. PubMed ID: 22112292
[TBL] [Abstract][Full Text] [Related]
36. Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer.
Cufer T; Vrdoljak E; Gaafar R; Erensoy I; Pemberton K;
Anticancer Drugs; 2006 Apr; 17(4):401-9. PubMed ID: 16549997
[TBL] [Abstract][Full Text] [Related]
37. Hyperthermia combined with chemotherapy
Fiorentini G; Sarti D; Mambrini A; Hammarberg Ferri I; Bonucci M; Sciacca PG; Ballerini M; Bonanno S; Milandri C; Nani R; Guadagni S; Dentico P; Fiorentini C
World J Clin Oncol; 2023 Jun; 14(6):215-226. PubMed ID: 37398545
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
39. Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): preliminary results of a phase II study.
Xu Y; Ma S; Ji Y; Sun X; Jiang H; Chen J; Du X; Zheng Y; Qiu G
Lung Cancer; 2011 Jun; 72(3):327-32. PubMed ID: 21056507
[TBL] [Abstract][Full Text] [Related]
40. High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial.
Hoffer LJ; Robitaille L; Zakarian R; Melnychuk D; Kavan P; Agulnik J; Cohen V; Small D; Miller WH
PLoS One; 2015; 10(4):e0120228. PubMed ID: 25848948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
